ESR1 and breast carcinoma: Our findings indicate that ERα suppresses Bmi1 expression by directly binding to the half-ERE site of the BMI1 promoter, thereby demonstrating a novel pathway by which ERα suppresses migration, invasion, and EMT in breast cancer cells, in addition to modulating Slug [2, 7] and NF-κB [6] pathways.